Partial gland cryoablation offers long-term success for prostate cancer patients

FHS
March 7, 2025
2:52 am

A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

Showdown at Masimo: Proxy battle targets CEO Kiani’s leadership, board

Masimo Chairman and CEO Joe Kiani is about to face his toughest challenge yet as leader of the patient monitoring company he founded more than

June 23, 2023

Nose-Picking Health Workers Had Higher COVID Risk

Surveyed hospital workers who admitted to picking their nose were three to four times more likely to wind up having a COVID infection, and the

August 4, 2023

Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase II trial

MVA-BN is marketed as Jynneos in the US and as Imvanex in Europe. Image credit: Sonia Bonet / Shutterstock. Bavarian Nordic is looking to expand

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.